One hundred years of somatic mutation theory of carcinogenesis: is it time to switch?

doi:10.1002/bies.201300160

. 2014 Jan;36(1):118-20.

doi: 10.1002/bies.201300160.

One hundred years of somatic mutation theory of carcinogenesis: is it time to switch?

Ana M Soto¹, Carlos Sonnenschein

Affiliations

Affiliation

¹ Department of Integrative Physiology & Pathobiology, Tufts University School of Medicine, Boston, MA, USA; Ecole Normale Supérieure, Centre Cavailles, Paris, France.

PMID: 24323923
PMCID: PMC4018816
DOI: 10.1002/bies.201300160

One hundred years of somatic mutation theory of carcinogenesis: is it time to switch?

Ana M Soto et al. Bioessays. 2014 Jan.

. 2014 Jan;36(1):118-20.

doi: 10.1002/bies.201300160.

Authors

Ana M Soto¹, Carlos Sonnenschein

Affiliation

¹ Department of Integrative Physiology & Pathobiology, Tufts University School of Medicine, Boston, MA, USA; Ecole Normale Supérieure, Centre Cavailles, Paris, France.

PMID: 24323923
PMCID: PMC4018816
DOI: 10.1002/bies.201300160

No abstract available

PubMed Disclaimer

Cited by

Ion Channel and Neurotransmitter Modulators as Electroceutical Approaches to the Control of Cancer.
Tuszynski J, Tilli TM, Levin M. Tuszynski J, et al. Curr Pharm Des. 2017;23(32):4827-4841. doi: 10.2174/1381612823666170530105837. Curr Pharm Des. 2017. PMID: 28554310 Free PMC article. Review.
Paradoxical Behavior of Oncogenes Undermines the Somatic Mutation Theory.
Monti N, Verna R, Piombarolo A, Querqui A, Bizzarri M, Fedeli V. Monti N, et al. Biomolecules. 2022 Apr 30;12(5):662. doi: 10.3390/biom12050662. Biomolecules. 2022. PMID: 35625590 Free PMC article.
Cancer research in need of a scientific revolution: Using 'paradigm shift' as a method of investigation.
Wion D, Appaix F, Burruss M, Berger F, van der Sanden B. Wion D, et al. J Biosci. 2015 Sep;40(3):657-66. doi: 10.1007/s12038-015-9543-3. J Biosci. 2015. PMID: 26333409 Review.
Just like the rest of evolution in Mother Nature, the evolution of cancers may be driven by natural selection, and not by haphazard mutations.
Zhang J, Lou X, Zellmer L, Liu S, Xu N, Liao DJ. Zhang J, et al. Oncoscience. 2014 Sep 22;1(9):580-90. doi: 10.18632/oncoscience.83. eCollection 2014. Oncoscience. 2014. PMID: 25594068 Free PMC article.
Mutation or not, what directly establishes a neoplastic state, namely cellular immortality and autonomy, still remains unknown and should be prioritized in our research.
Zhu S, Wang J, Zellmer L, Xu N, Liu M, Hu Y, Ma H, Deng F, Yang W, Liao DJ. Zhu S, et al. J Cancer. 2022 Jul 4;13(9):2810-2843. doi: 10.7150/jca.72628. eCollection 2022. J Cancer. 2022. PMID: 35912015 Free PMC article. Review.

See all "Cited by" articles

References

1. Oppenheimer J. Essays in the History of Embryology. Cambridge, MA: MIT Press; 1967. p. 80.
1. Gilbert SF, Sarkar S. Embracing complexity: organicism for the 21st century. Dev Dyn. 2000;219:1–9. - PubMed
1. Wunderlich V. Early references to the mutational origin of cancer. Int J Epidemiol. 2007;36:246–7. - PubMed
1. Sonnenschein C, Soto AM. The Society of Cells: Cancer and Control of Cell Proliferation. New York, NY: Springer Verlag; 1999.
1. Soto AM, Sonnenschein C. The tissue organization field theory of cancer: a testable replacement for the somatic mutation theory. BioEssays. 2011;33:332–40. - PMC - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Grants and funding

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations

[1] Oppenheimer J. Essays in the History of Embryology. Cambridge, MA: MIT Press; 1967. p. 80.

[2] Oppenheimer J. Essays in the History of Embryology. Cambridge, MA: MIT Press; 1967. p. 80.

[3] Gilbert SF, Sarkar S. Embracing complexity: organicism for the 21st century. Dev Dyn. 2000;219:1–9. - PubMed

[4] Gilbert SF, Sarkar S. Embracing complexity: organicism for the 21st century. Dev Dyn. 2000;219:1–9. - PubMed

[5] Wunderlich V. Early references to the mutational origin of cancer. Int J Epidemiol. 2007;36:246–7. - PubMed

[6] Wunderlich V. Early references to the mutational origin of cancer. Int J Epidemiol. 2007;36:246–7. - PubMed

[7] Sonnenschein C, Soto AM. The Society of Cells: Cancer and Control of Cell Proliferation. New York, NY: Springer Verlag; 1999.

[8] Sonnenschein C, Soto AM. The Society of Cells: Cancer and Control of Cell Proliferation. New York, NY: Springer Verlag; 1999.

[9] Soto AM, Sonnenschein C. The tissue organization field theory of cancer: a testable replacement for the somatic mutation theory. BioEssays. 2011;33:332–40. - PMC - PubMed

[10] Soto AM, Sonnenschein C. The tissue organization field theory of cancer: a testable replacement for the somatic mutation theory. BioEssays. 2011;33:332–40. - PMC - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

One hundred years of somatic mutation theory of carcinogenesis: is it time to switch?

Affiliation

One hundred years of somatic mutation theory of carcinogenesis: is it time to switch?

Authors

Affiliation

Similar articles

Cited by

References

Publication types

MeSH terms

Grants and funding

LinkOut - more resources

Full Text Sources

Other Literature Sources